Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN.

Cancer Res. 2003 Apr 1;63(7):1602-7.

2.

Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.

Shirahata M, Iwao-Koizumi K, Saito S, Ueno N, Oda M, Hashimoto N, Takahashi JA, Kato K.

Clin Cancer Res. 2007 Dec 15;13(24):7341-56.

3.

Using gene expression profiling to identify a prognostic molecular spectrum in gliomas.

Shirahata M, Oba S, Iwao-Koizumi K, Saito S, Ueno N, Oda M, Hashimoto N, Ishii S, Takahashi JA, Kato K.

Cancer Sci. 2009 Jan;100(1):165-72. doi: 10.1111/j.1349-7006.2008.01002.x.

5.

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, French PJ.

Cancer Res. 2009 Dec 1;69(23):9065-72. doi: 10.1158/0008-5472.CAN-09-2307.

6.

Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.

Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W.

Oncol Rep. 2005 Sep;14(3):651-6.

PMID:
16077969
8.

[Histological and molecular classification of gliomas].

Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Review. French.

PMID:
18565348
9.

Gene expression profile as a prognostic factor in high-grade gliomas.

Czernicki T, Zegarska J, Paczek L, Cukrowska B, Grajkowska W, Zajaczkowska A, Brudzewski K, Ulaczyk J, Marchel A.

Int J Oncol. 2007 Jan;30(1):55-64.

PMID:
17143512
10.

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.

Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, Yates AJ, Boyett JM, Finlay JL.

Neurosurgery. 2002 Jun;50(6):1238-44; discussion 1244-5.

PMID:
12015841
11.

Gene expression profiling of gliomas strongly predicts survival.

Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF.

Cancer Res. 2004 Sep 15;64(18):6503-10.

12.

[Histological classification of human gliomas: state of art and controversies].

Figarella-Branger D, Bouvier C.

Bull Cancer. 2005 Apr;92(4):301-9. French.

13.

Identification of expressed genes characterizing long-term survival in malignant glioma patients.

Yamanaka R, Arao T, Yajima N, Tsuchiya N, Homma J, Tanaka R, Sano M, Oide A, Sekijima M, Nishio K.

Oncogene. 2006 Sep 28;25(44):5994-6002.

PMID:
16652150
14.

Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.

Marko NF, Prayson RA, Barnett GH, Weil RJ.

Genomics. 2010 Jan;95(1):16-24. doi: 10.1016/j.ygeno.2009.09.007.

15.

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A.

Acta Neuropathol. 2010 Dec;120(6):707-18. doi: 10.1007/s00401-010-0781-z.

PMID:
21088844
16.

Genetic analysis to complement histopathological diagnosis of brain tumors.

Nakamura M, Shimada K, Ishida E, Nakase H, Konishi N.

Histol Histopathol. 2007 Mar;22(3):327-35. Review.

PMID:
17163407
17.

Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.

Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W.

Histol Histopathol. 2000 Jul;15(3):971-81. Review.

PMID:
10963139
18.

YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.

Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO.

Clin Cancer Res. 2005 Mar 15;11(6):2258-64.

19.

Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.

Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.

Clin Cancer Res. 2005 Jan 1;11(1):267-72.

20.

Beyond grade: molecular pathology of malignant gliomas.

Sulman EP, Guerrero M, Aldape K.

Semin Radiat Oncol. 2009 Jul;19(3):142-9. doi: 10.1016/j.semradonc.2009.02.001.

PMID:
19464628
Items per page

Supplemental Content

Support Center